The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 138 affiliates in 47 countries and 41,300 employees. Since it was founded in 1885, the independent, family-owned company has been committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine.
PT Boehringer Ingelheim Indonesia has more than 500 employees throughout Indonesia and has 4 business focuses; Prescription Medicines, Consumer Health Care, Animal Health and Industrial Customer Business.
If you are an organized, systematic and motivated individual that possess passion to serve with excellence then this could be perfect opportunity for you.
To be eligible for this opportunity you must:
A new vision for a new world
Our corporate vision - "Value through Innovation": The objectives and beliefs of Boehringer Ingelheim can be summed up in a single phrase: Value through Innovation. This vision has helped us to build on our strengths and make the most of our distinctive character. In a competitive and fast-changing world, the value of products, services and companies is constantly changing. Real customer value today can only be created by constantly developing new solutions and doing what we already do better.
Lead & Learn: The present phase in our evolution is Lead & Learn. Since 2004, it outlines ways in which Boehringer Ingelheim realises and delivers Value through Innovation. As our corporate culture, Lead & Learn is about all the people at Boehringer Ingelheim and how they work together.
A new vision for the corporate culture: Lead & Learn superseded the concept of Vision & Leadership that was established in 1993 by the Shareholders and the Board of Managing Directors of the Boehringer Ingelheim corporation. The Vision, created for Boehringer Ingelheim worldwide, was built around the corporate vision of Value through Innovation. Since then, our corporate culture always was guided by this vision.
The Annual Report 2010 provides the EHS figures for the last five years (2006-2010). The impact on the environment is described both in absolute figures as well as normalized in relation to the annual sales volumes (indices with 2006 as base year). For our environmental performance our production as well as research and development sites were considered.
Submit Application
Please send us your application with comprehensive resume and recent photograph to
our email:
recruitment@boehringer-ingelheim.com
(email capacity not more than 300kb)
Attachment files given from .zip files, do not accept files in .rar or pdf
The following EHS figures (2006 – 2010) are presented in our Annual Report 2010:
Medical Representative (MR)
Bali, Balikpapan (Kalimantan Timur), Palembang (Sumatera Selatan)
Responsibilities:
The Medical Representative is responsible for the implementing sales activities in his/her area of responsibilities. The incumbent will implement the division’s sales/marketing plan in his/her area to assure maximum distribution and market penetration of division’s products within. The incumbent ensures consistent sales activities to meet or exceed sales goals
Requirements:
- Male/Female, age max. 30 years old, min. Diploma Degree (D3) or Bachelor Degree (S1) from reputable University with any discipline.
- Preferably having minimum of 1 year experience working as Medical Representative from Pharmaceutical Industry background division Cardiovascular and Metabolic.
- Self driven, autonomous, analytic and creative attitude, excellent communication skills (orally and written), ability to handle high workload, can tolerate stress and good organizational skills.
- A strong understanding of the role and sales process.
- Ready to be placed in Palembang, Bali, and Balikpapan area
If you have the required qualifications and have the commitment to teamwork and innovation that we are seeking, then this organization is for you. In return we offer a competitive remuneration package and a genuine interest in your development and progression.
Tidak ada komentar:
Posting Komentar